Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

ILC1 cells contribute to hair loss in alopecia areata.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Understanding tissue remodeling can help create precise treatments for various organ issues.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Upadacitinib improved multiple immune-related conditions in one patient.

Keratin 17 is crucial for normal hair growth by regulating hair cycle transitions with TNFα.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Leflunomide and anthralin may effectively treat severe alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Pumpkin seeds may help expel parasites, but findings are retracted.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Iron deficiency anemia can cause itching, which often improves with iron supplements.